ClinicalThought


Share

Program Content

Activities

  • Claudin18.2 in Gastric Cancer
    Considering a Claudin18.2-Targeted Agent in the Current Treatment Landscape for HER2-Negative Gastric Cancers
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 14, 2023

Faculty

cover img faculity

Gregory Botta, MD, PhD

Clinical Professor of Medicine
Department of Medicine/Hematology & Oncology
University of California San Diego
La Jolla, California

Provided by

ProCE Banner

Supporters

Supported by educational grants from Astellas and Bristol Myers Squibb.

Astellas

Bristol Myers Squibb